Evaluation of Long-term Efficacy of Treatment With Lamazym
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The overall objective is to evaluate the long-term efficacy of Lamazym i.v. treatment in
patients with alpha-Mannosidosis previously enrolled in Lamazym trials and currently
receiving the treatment according to the AfterCare Program.